JD Health International Inc.

SEHK:6618 Rapport sur les actions

Capitalisation boursière : HK$92.2b

JD Health International Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Enlin Jin

Directeur général

CN¥8.4m

Rémunération totale

Pourcentage du salaire du PDG15.0%
Durée du mandat du directeur général3.2yrs
Propriété du PDG0.01%
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administration4yrs

Mises à jour récentes de la gestion

This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate

Jun 14
This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate

Recent updates

Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects

Nov 04
Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects

Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?

Sep 26
Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?

A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Sep 05
A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Aug 19
Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence

Aug 08
The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence

Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price

Jul 21
Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price

This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate

Jun 14
This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate

Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

May 21
Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

Apr 17
JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return

Apr 08
JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return

At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?

Mar 01
At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?

Revenues Tell The Story For JD Health International Inc. (HKG:6618)

Jan 16
Revenues Tell The Story For JD Health International Inc. (HKG:6618)

JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends

Dec 07
JD Health International (HKG:6618) Will Want To Turn Around Its Return Trends

What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?

Nov 20
What Does JD Health International Inc.'s (HKG:6618) Share Price Indicate?

JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate

Nov 02
JD Health International Inc. (HKG:6618) Shares Could Be 44% Below Their Intrinsic Value Estimate

Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

Aug 21
Be Wary Of JD Health International (HKG:6618) And Its Returns On Capital

JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price

Aug 03
JD Health International Inc.'s (HKG:6618) Intrinsic Value Is Potentially 32% Above Its Share Price

JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues

Jun 08
JD Health International Inc.'s (HKG:6618) Price In Tune With Revenues

Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?

Apr 19
Is JD Health International Inc. (HKG:6618) Trading At A 32% Discount?

Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

Dec 29
Estimating The Intrinsic Value Of JD Health International Inc. (HKG:6618)

Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?

Sep 14
Is There An Opportunity With JD Health International Inc.'s (HKG:6618) 31% Undervaluation?

A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Dec 04
A Look At The Fair Value Of JD Health International Inc. (HKG:6618)

Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Mar 08
Calculating The Fair Value Of JD Health International Inc. (HKG:6618)

Analyse de la rémunération des PDG

Comment la rémunération de Enlin Jin a-t-elle évolué par rapport aux bénéfices de JD Health International?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

CN¥3b

Mar 31 2024n/an/a

CN¥2b

Dec 31 2023CN¥8mCN¥1m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥1b

Dec 31 2022CN¥8mCN¥1m

CN¥380m

Sep 30 2022n/an/a

-CN¥7m

Jun 30 2022n/an/a

-CN¥395m

Mar 31 2022n/an/a

-CN¥734m

Dec 31 2021CN¥3mCN¥301k

-CN¥1b

Rémunération vs marché: La rémunération totale de Enlin ($USD 1.16M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 888.51K ).

Rémunération et revenus: La rémunération de Enlin a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Enlin Jin (43 yo)

3.2yrs

Titularisation

CN¥8,385,000

Compensation

Mr. Enlin Jin is Chief Executive Officer & Executive Director of JD Health International Inc. from September 06, 2021. Mr. Jin has extensive experience in pharmaceuticals and TMT industry. He serves as the...


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Enlin Jin
CEO & Executive Director3.2yrsCN¥8.39m0.011%
HK$ 10.0m
Ying Wu
Independent Non-Executive Director2.6yrsCN¥818.00k0.00030%
HK$ 276.6k
Qiangdong Liu
Chairman4.2yrsCN¥407.82m0.56%
HK$ 512.1m
Qingqing Yi
Non-Executive Director4.3yrspas de donnéespas de données
Xingyao Chen
Independent Non-Executive Director4yrsCN¥476.00k0.00018%
HK$ 166.0k
Ling Li
Independent Non-Executive Director4yrsCN¥476.00k0.00018%
HK$ 166.0k
Jiyu Zhang
Independent Non-Executive Director3.7yrsCN¥463.00k0.00019%
HK$ 175.2k

4.0yrs

Durée moyenne de l'emploi

51yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 6618 sont considérés comme expérimentés (ancienneté moyenne 4 ans).